Explain this page
Arphra AIPlain-English read on Aramark’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +9.00% | +7.83% | +8.14% | +8.19% | +5.78% | +7.57% | +7.38% | +7.54% | +7.46% |
| Operating margin | +1.58% | +3.03% | +3.89% | +4.06% | +4.28% | +4.18% | +4.06% | +4.11% | +4.15% |
| EBITDA margin | +6.87% | +6.06% | +8.96% | +6.84% | +6.75% | +7.32% | +7.68% | +7.30% | +7.33% |
| EBIT margin | +2.32% | +3.16% | +6.41% | +4.33% | +4.17% | +5.05% | +4.85% | +4.99% | +4.83% |
| Pre-tax margin | -1.10% | +0.34% | +3.50% | +2.10% | +2.33% | +2.58% | +2.63% | +2.64% | +2.71% |
| Net margin | -0.75% | +1.42% | +4.19% | +1.51% | +1.76% | +2.54% | +2.51% | +2.55% | +2.53% |
| Cost structure | |||||||||
| Cost of revenue / sales | +91.00% | +92.17% | +91.86% | +91.81% | +94.22% | +92.50% | +91.89% | +91.06% | +92.47% |
| R&D intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A intensity | +2.87% | +1.89% | +1.70% | +1.63% | +1.50% | +1.65% | +1.58% | +1.65% | +1.59% |
| Effective tax rate | — | +17.86% | +20.66% | +28.22% | +24.06% | +24.19% | +25.11% | +23.72% | +24.02% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | — | +6.40% | — | — | +10.32% | +15.35% | +15.19% | +15.24% | +15.19% |
| Return on assets (ROA) | — | +1.29% | — | — | +2.45% | +3.53% | +3.56% | +3.54% | +3.50% |
| Return on capital (ROC) | — | +3.84% | — | — | +8.91% | +8.88% | +8.53% | +8.54% | +8.65% |
| Return on invested capital (ROIC) | — | +1.80% | — | — | +3.67% | +5.40% | +5.26% | +5.29% | +5.27% |
| Asset turnover | — | +90.75% | — | — | +139.10% | +138.97% | +141.99% | +138.78% | +138.44% |
| DuPont · ROE decomposition | |||||||||
| Net margin | -0.75% | +1.42% | +4.19% | +1.51% | +1.76% | +2.54% | +2.51% | +2.55% | +2.53% |
| Asset turnover (× revenue / assets) | — | +90.75% | — | — | +139.10% | +138.97% | +141.99% | +138.78% | +138.44% |
| Equity multiplier (× assets / equity) | — | +496.38% | — | — | +420.74% | +434.61% | +426.81% | +430.84% | +433.63% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | — | 0.91 | — | — | 1.39 | 1.39 | 1.42 | 1.39 | 1.38 |
| Fixed-asset turnover | — | 5.22 | — | — | 7.60 | — | — | — | — |
| Inventory turnover | — | 22.84 | — | — | 41.64 | — | — | — | — |
| Receivables turnover | — | 6.37 | — | — | 8.27 | — | — | — | — |
| Payables turnover | — | 9.54 | — | — | 11.45 | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | — | 57.28 | — | — | 44.12 | — | — | — | — |
| Days inventory outstanding (DIO) | — | 15.98 | — | — | 8.77 | — | — | — | — |
| Days payables outstanding (DPO) | — | 38.28 | — | — | 31.88 | — | — | — | — |
| Cash conversion cycle | — | 34.99 | — | — | 21.01 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | — | 3.57 | — | — | 2.82 | 1.99 | 2.04 | 1.93 | 1.99 |
| FCF / Net income | — | 1.70 | — | — | 1.39 | 0.97 | 0.99 | 0.95 | 0.98 |
| FCF margin | — | +2.41% | — | — | +2.46% | +2.47% | +2.49% | +2.43% | +2.48% |
| OCF margin | — | +5.07% | — | — | +4.98% | +5.05% | +5.11% | +4.92% | +5.04% |
| CapEx / Revenue | — | +2.66% | — | — | +2.52% | +2.58% | +2.55% | +2.51% | +2.50% |
| CapEx / D&A | — | 0.69 | — | — | 0.98 | — | — | — | — |
| Stock-based comp / Revenue | — | +0.70% | — | — | +0.32% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | -0.36 | 0.75 | 2.57 | 0.99 | 1.22 | 2.25 | 2.69 | 3.10 | 3.89 |
| EPS · basic | -0.36 | 0.76 | 2.59 | 1.00 | 1.24 | 2.27 | 2.74 | 3.10 | 3.97 |
| Book value / share | — | 11.73 | — | — | 11.83 | 12.30 | 13.15 | 14.16 | 15.88 |
| Tangible BV / share | — | -18.49 | — | — | -13.42 | 12.30 | 13.15 | 14.16 | 15.88 |
| Sales / share | 47.48 | 52.83 | 61.25 | 65.37 | 69.22 | 74.26 | 79.67 | 84.64 | 95.33 |
| Operating CF / share | — | 2.68 | — | — | 3.45 | 3.75 | 4.07 | 4.16 | 4.80 |
| Free cash flow / share | — | 1.27 | — | — | 1.70 | 1.84 | 1.99 | 2.06 | 2.37 |
| Dividends / share | — | 0.44 | — | — | 0.41 | 0.46 | 0.47 | 0.50 | 0.56 |
| Payout ratio | — | +58.16% | — | — | +33.95% | +24.15% | +23.43% | +23.18% | +23.13% |
| Retention ratio | — | +41.84% | — | — | +66.05% | +75.85% | +76.57% | +76.82% | +76.87% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | +13.16% | +17.50% | +8.19% | +6.35% | +7.89% | +7.03% | +5.99% | +12.09% | +9.71% |
| Gross profit · YoY | — | -1.58% | +22.10% | +8.95% | -24.93% | +41.22% | +4.37% | +8.29% | +10.80% | +7.16% |
| Profit | ||||||||||
| Operating income · YoY | — | +116.98% | +50.47% | +13.04% | +12.08% | +5.40% | +3.96% | +7.40% | +13.15% | +23.77% |
| EBITDA · YoY | — | -0.18% | +73.56% | -17.43% | +4.97% | +17.02% | +12.25% | +0.79% | +12.60% | +10.60% |
| Net income · YoY | — | +314.11% | +246.61% | -61.06% | +24.33% | +55.45% | +5.54% | +7.83% | +11.27% | — |
| Operating | ||||||||||
| EBIT · YoY | — | +53.84% | +138.57% | -26.85% | +2.43% | +30.43% | +2.82% | +9.21% | +8.45% | +20.24% |
| R&D · YoY | — | — | — | — | — | — | — | — | — | — |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | +308.33% | +242.67% | -61.48% | +23.23% | +84.50% | +19.42% | +15.41% | +25.45% | — |
| EPS · basic · YoY | — | +311.11% | +240.79% | -61.39% | +24.00% | +82.93% | +20.79% | +13.21% | +28.07% | — |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | — | $7.79B | — | — | $5.72B | $6.1B | $6.65B | $7.12B | $7.95B |
| Net debt | — | $7.46B | — | — | $5.08B | $5.42B | $5.91B | $6.33B | $7.07B |
| Net debt / EBITDA | — | 8.98 | — | — | 4.07 | 3.71 | 3.60 | 3.83 | 3.80 |
| Debt / equity | — | 2.56 | — | — | 1.81 | 1.84 | 1.89 | 1.88 | 1.88 |
| Debt / assets | — | +51.62% | — | — | +43.01% | +42.43% | +44.19% | +43.62% | +43.37% |
| Equity / assets | — | +20.15% | — | — | +23.77% | +23.01% | +23.43% | +23.21% | +23.06% |
| Coverage | |||||||||
| EBITDA / interest expense | 2.01 | 2.16 | 3.08 | 3.06 | 3.43 | 3.11 | 3.26 | 3.08 | 3.14 |
| Operating income / interest | 0.46 | 1.08 | 1.34 | 1.82 | 2.17 | 1.78 | 1.73 | 1.74 | 1.78 |
| Interest expense | $413.71M | $384.86M | $467.29M | $389.19M | $364.38M | $469.7M | $502.85M | $536.58M | $593.24M |
| Liquidity | |||||||||
| Current ratio | — | 1.00 | — | — | 0.99 | — | — | — | — |
| Quick ratio | — | 0.75 | — | — | 0.81 | — | — | — | — |
| Cash ratio | — | 0.10 | — | — | 0.18 | — | — | — | — |
| Working capital | — | $6.1M | — | — | -$23.83M | — | — | — | — |
| Working capital / revenue | — | +0.04% | — | — | -0.13% | — | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).